Literature DB >> 10500620

Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation.

M García González1, A Hernandez-Madrid, A Lopez-Sanromán, A Candela, J Nuño, R Barcena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10500620     DOI： 10.1016/s0041-1345(99)00381-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

2.  Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease.

Authors:  Andrew O Zurick; Bret J Spier; Thomas C Teelin; Katelin R Lorenze; Cesar Alberte; Steven Zacks; Mary J Lindstrom; Patrick R Pfau; Kimberly Selzman
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

3.  Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; David D Douglas
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 4.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

5.  The Relationship between QT Interval Dispersion and End-Stage Liver Disease Score in the Patients Undergoing Orthotopic Liver Transplantation.

Authors:  Moghgan Zahmatkeshan; Ebrahim Fallahzadeh; Seyedeh Sadat Najib; Hamid Amoozgar; Seyed Ali Malekhosseini; Saman Nikeghbalian
Journal:  Int Cardiovasc Res J       Date:  2013-12-01

6.  Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis.

Authors:  Axel Josefsson; Michael Fu; Einar Björnsson; Evangelos Kalaitzakis
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.